Nea Partners 16, L.p.

MIRM

10% OWNER · MIRUM PHARMACEUTICALS, INC. · CIK 0001712881

FILING MIX · LIFETIME67%/33%

BUYS

SELLS

TOTAL VALUE

$16.78M

COMPANIES

ACTIVE SINCE

Apr 2020

HOLDINGS NOW

12,077,106

AVG SELL PX

$2.66

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

6 backtested trades · 8 horizons · 1 pendingHow are these numbers computed? →

Forward-return performance of every backtestable P/S trade by Nea Partners 16, L.p., measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.

HORIZON	TRADES	WIN RATE	INSIDER RETURN	SPY RETURN	MEAN EXCESS	MEDIAN EXCESS	T-STAT
7d	6	+83.33%	+16.52%	+0.46%	+16.06%	+10.84%	—
14d	6	+83.33%	+6.02%	+1.03%	+4.99%	+0.52%	—
30d	6	+16.67%	-13.70%	+1.78%	-15.48%	-14.85%	—
60d	6	+16.67%	-28.30%	+0.77%	-29.07%	-44.40%	—
90d	6	+33.33%	-9.53%	+0.86%	-10.39%	-43.38%	—
180d	6	+50.00%	+74.02%	-1.24%	+75.26%	+82.67%	—
1y	6	+50.00%	+2.86%	-4.17%	+7.02%	+25.51%	—
2y	6(1 pending)	+80.00%	+15.28%	+4.24%	+11.04%	+55.89%	—

How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.

Holdings over time

MIRM · 30,000 shares · as of Jun 13, 2023

Trading cadence · quarterly flow

BUY ● SELL ●

2020

2021

2022

2023

2024

FLOW · 8 buys / 4 sellsCOVERAGE · 19 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED	DETAILS
MRKR MARKER THERAPEUTICS, INC.	PURCHASE	554,250	$3.20	$1.77M	1,625,678	Dec 23, 2024	Dec 23, 2024 ↗	View →
MIRM MIRUM PHARMACEUTICALS, INC.	SALE	2,000,000	—	—	2,186,243	Jun 13, 2023	Jun 15, 2023 ↗	View →
MIRM MIRUM PHARMACEUTICALS, INC.	SALE	30,000	—	—	0	Jun 13, 2023	Jun 15, 2023 ↗	View →
MIRM MIRUM PHARMACEUTICALS, INC.	PURCHASE	30,000	—	—	30,000	Jun 13, 2023	Jun 15, 2023 ↗	View →
TRVI TREVI THERAPEUTICS, INC.	PURCHASE	2,631,578	$1.90	$5.00M	10,421,428	Apr 11, 2022	Apr 13, 2022 ↗	View →
TRVI TREVI THERAPEUTICS, INC.	PURCHASE	1,851,852	—	—	1,851,852	Oct 18, 2021	Oct 19, 2021 ↗	View →
TRVI TREVI THERAPEUTICS, INC.	PURCHASE	1,851,852	—	—	1,851,852	Oct 18, 2021	Oct 19, 2021 ↗	View →
TRVI TREVI THERAPEUTICS, INC.	PURCHASE	1,851,852	—	—	7,789,850	Oct 18, 2021	Oct 19, 2021 ↗	View →
MRKR MARKER THERAPEUTICS, INC.	PURCHASE	5,714,285	$1.75	$10.00M	10,714,285	Mar 16, 2021	Mar 18, 2021 ↗	View →
TRVI TREVI THERAPEUTICS, INC.	PURCHASE	1,500,000	$0.00	$1.5K	5,938,562	Apr 3, 2020	Apr 13, 2020 ↗	View →
TRVI TREVI THERAPEUTICS, INC.	SALE	564	$2.66	$1.5K	5,937,998	Apr 3, 2020	Apr 13, 2020 ↗	View →
TRVI TREVI THERAPEUTICS, INC.	SALE	1,500,000	—	—	0	Apr 3, 2020	Apr 13, 2020 ↗	View →

Other insiders · MIRM

Loading peer insiders…

About this filer

CIK 0001712881

ROLE

10% Owner

PRIMARY

MIRM

COMPANIES

ACTIVE SINCE

Apr 2020

MARKETPEEL · /INSIDER/0001712881DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

Nea Partners 16, L.p.

The morning brief, before the bell.